MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with A

Acarbose

Acarbose 50mg tablets

No stability information

Stability notes for Acarbose 50mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Acarbose 50mg tablets
Acarbose 50mg tablets (A A H Pharmaceuticals Ltd)
Acarbose 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Acarbose 50mg tablets (Medihealth (Northern) Ltd)
Acarbose 50mg tablets (Morningside Healthcare Ltd)
Acarbose 50mg tablets (Phoenix Healthcare Distribution Ltd)
Acarbose 50mg tablets (Sigma Pharmaceuticals Plc)

Acarbose 100mg tablets

No stability information

Stability notes for Acarbose 100mg tablets

There are no stability notes for this medicine.

Suppliers (7) of Acarbose 100mg tablets
Acarbose 100mg tablets (A A H Pharmaceuticals Ltd)
Acarbose 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Acarbose 100mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Acarbose 100mg tablets (Medihealth (Northern) Ltd)
Acarbose 100mg tablets (Morningside Healthcare Ltd)
Acarbose 100mg tablets (Phoenix Healthcare Distribution Ltd)
Acarbose 100mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.